Prostate cancer and its mimics at multiparametric prostate MRI

British Journal of Radiology

Volumn 87, Issue 1037, 2014, Pages

  Yu, J ^a   Fulcher, A S ^a   Turner, M A ^a   Cockrell, C H ^a   Cote, E P ^b   Wallace, T J ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Bon Secours Health System   (United States)

^c Division of Virginia Urology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHRONIC PROSTATITIS; EARLY DIAGNOSIS; GRANULOMATOSIS; GRANULOMATOUS PROSTATITIS; HUMAN; HYPERTROPHIC NODULE; MALE; MULTIPARAMETRIC PROSTATE NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTOPERATIVE COMPLICATION; PROSTATE; PROSTATE CARCINOMA; PROSTATE CENTRAL GLAND; PROSTATE CENTRAL ZONE; PROSTATE DISEASE; PROSTATE PERIPHERAL ZONE; PROSTATE TRANSITIONAL ZONE; PROSTATECTOMY; PROSTATITIS; PSEUDOLESION; RADIATION EXPOSURE; RADIOLOGIST; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; DIFFERENTIAL DIAGNOSIS; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROCEDURES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RADIATION RESPONSE; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROSTATITIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84907546644     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20130659     Document Type: Review

References (14)

1. Vargas HA, Akin O, Franiel T, Mazaheri Y, Zheng J, Moskowitz C, et al. Diffusionweighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 2011; 259: 775-84. doi: 10.1148/radiol.11102066
2. Somford DM, Fütterer JJ, Hambrock T, Barentsz JO. Diffusion and perfusion MR imaging of the prostate. Magn Reson Imaging Clin N Am 2008; 16: 685-95. doi: 10.1016/ j.mric.2008.07.002
3. Kirkham APS, Haslam P, Keanie JY, McCafferty I, Padhani AR, Punwani S, et al. Prostate MRI: who, when, and how? Report from a UK consensus meeting. Clin Radiol 2013; 68: 1016-23. doi: 10.1016/j. crad.2013.03.030
4. Akin O, Sala E, Moskowitz CS, Kuroiwa K, Ishill NM, Pucar D, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006; 239: 784-92. doi: 10.1148/radiol.2392050949
5. Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746-57. doi: 10.1007/s00330-011- 2377-y
6. Chesnais AL, Niaf E, Bratan F, Mége- Lechevallier FM, Roche S, Rabilloud M, et al. Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI. Clin Radiol 2013; 68: 323-30. doi: 10.1016/j.crad.2013.01.018
7. Westphalen AC, Coakley FV, Roach M, McCulloch CE, Kurhanewicz J. Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. Radiology 2010; 256: 485-92. doi: 10.1148/ radiol.10092314
8. Vargas HA, Wassberg C, Akin O, Hricak H. MR imaging of treated prostate cancer. Radiology 2012; 262: 26-42. doi: 10.1148/ radiol.11101996
9. Shukla-Dave A, Hricak H, Eberhardt SC, Olgac S, Muruganandham M, Scardino PT, et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings - initial observations. Radiology 2004; 231: 717-24. doi: 10.1148/radiol.2313031391
10. Rosenkrantz AB, Taneja SS. Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI. AJR Am J Roentgenol 2014; 202: 109-20. doi: 10.2214/AJR.13.10699
11. Schiebler ML, Tomaszewski JE, Bezzi M, Pollack HM, Kressel HY, Cohen EK, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Radiology 1989; 172: 131-7.
12. Sato C, Naganawa S, Nakamura T, Kumada H, Miura S, Takizawa O, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005; 21: 258-62. doi: 10.1002/jmri.20251
13. Akin O, Gultekin DH, Vargas HA, Zheng J, Moskowitz C, Pei X, et al. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. Eur Radiol 2011; 21: 1970-8.
14. Kiyoshima k, Yokomizo A, Yoshida T, Tomita K, Yonemasu H, Nakamura M, et al. Anatomical features of periprostatic tissue and its surroundings: a histological analysis of 79 radical retropubic prostatectomy specimens. J Clin Oncol 2004; 34: 463-8.